13

October 13, 2014

Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive miRNA-188 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, 13/October/2014, 21.49

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of […]
October 13, 2014

Chemopreventive therapy against Human Cancer: Natural product Cucurbitacin I inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 13/October/2014, 18.59

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold E, Somwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and the US National […]
October 13, 2014

MiRNA-based Regenerative therapy for T2D: Argonaute-2 (Ago2) promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 13/October/2014, 12.21 pm

A recent study from the Mammalian Genetics Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, London, United Kingdom; and School of Medicine, King’s College […]
October 13, 2014

Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 13/October/2014, 11.58 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal […]